Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Pre-Eclampsia
100%
Fetus Growth
66%
Pyometra
33%
Urogynecology
33%
Tamsulosin
33%
Homologous Recombination
33%
Salivary Gland Carcinoma
33%
Pelvic Organ Prolapse
33%
Cross Sectional Study
33%
Pregnant Woman
33%
BRCA1
33%
Hysterectomy
33%
Surgical Infection
33%
Antimicrobial Agent
33%
Retrospective Cohort Study
33%
Cefazolin
33%
Benign Tumor
33%
Interventional Radiology
33%
Biological Marker
26%
Metronidazole
20%
Maternal Morbidity
18%
Infection
16%
Perinatal Mortality
15%
Perinatal Morbidity
15%
Salivary Gland Neoplasm
13%
Uterine Artery
11%
Vascular Resistance
11%
Evolutionary Adaptation
11%
Hypoxia Inducible Factor
11%
Oxidative Stress
11%
Trophoblast
11%
Physiological Adaptation
11%
Placenta Disorder
11%
Adverse Outcome
11%
Blood Flow
11%
Environmental Factor
11%
High Output Cardiac Failure
8%
Systolic Function
8%
Mons Pubis
8%
Ecchymosis
8%
Mixed Incontinence
8%
Pathophysiology
7%
Newborn Mortality
6%
Ovarian Cancer
5%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
40%
Experimental Model
33%
Androgen Receptor
33%
Tamsulosin
33%
Myeloid
33%
Molecular Mechanism
33%
Immune Response
33%
Cancer Mortality
33%
Estrogen Receptor
13%
Hematopoietic Cell
13%
Biogenesis
13%
Receptor Gene
11%
Perinatal Morbidity
11%
Translating (Language)
11%
Maternal Morbidity
11%
Perinatal Mortality
11%
Genetic Profiling
8%
Cancer Genomics
8%
RNA Sequence
8%
Differential Gene Expression
8%
Cancer Staging
8%
Cell Communication
6%
Immunomodulation
6%
Diagnostic Biomarker
6%
Vesicular Transporter
6%
Nucleic Acid
6%
Non-Coding RNA
6%
Mediator
6%
Metabolite
6%
Carcinogenesis
6%
Regulatory Network
5%
Immunology and Microbiology
Inflammation
33%
Fetus Growth
33%
Microbiome
33%
Tumor Cell
33%
Microsatellite Instability
33%
Dioxygen
22%
Immune Response
16%
Immune System
16%
Cancer Mortality
16%
Perinatal Mortality
11%
Hypoxia Inducible Factor
11%
Trophoblast
11%
Perinatal Morbidity
11%
Uterine Artery
11%
Artery Diameter
11%
Vascular Resistance
11%
Evolutionary Adaptation
11%
Blood Flow
11%
Immune Checkpoint Inhibitor
9%
Therapeutic Target
6%